Skip to content

Rigel Pharmaceuticals RIGL Investment Purchases

Investment Purchases at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$148.18M-15.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$58.3M+692%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$43.41M+2,106%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$192.76M-38.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$131M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's investment purchases?
Rigel Pharmaceuticals (RIGL) reported investment purchases of $23.92M in Q1 2026.
How has Rigel Pharmaceuticals's investment purchases changed year-over-year?
Rigel Pharmaceuticals's investment purchases increased by 10.5% year-over-year, from $21.65M to $23.92M.
What is the long-term trend for Rigel Pharmaceuticals's investment purchases?
Over 3 years (2021 to 2025), Rigel Pharmaceuticals's investment purchases has grown at a 2.8% compound annual growth rate (CAGR), from $141.46M to $153.49M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.